• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Haemophilia B - Articles and news items

NovoSeven resolved 96.5% of bleeds in haemophilia A or B sufferers

Industry news / 6 December 2016 / Niamh Louise Marriott, Digital Editor

NovoSeven, a portable room temperature stable recombinant activated factor VIIa, resolved 96.5% of bleeds demonstrating efficacy with haemophilia…

Alprolix approved in Switzerland for the treatment of haemophilia B

Industry news / 31 October 2016 / Niamh Louise Marriott, Digital Content Producer

The Swiss Agency for Therapeutic Products, Swissmedic, has approved Alprolix (eftrenonacog alfa) for the treatment of haemophilia B…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +